1. Home
  2. PDLB vs AQST Comparison

PDLB vs AQST Comparison

Compare PDLB & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • AQST
  • Stock Information
  • Founded
  • PDLB 1960
  • AQST 2004
  • Country
  • PDLB United States
  • AQST United States
  • Employees
  • PDLB N/A
  • AQST N/A
  • Industry
  • PDLB
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDLB
  • AQST Health Care
  • Exchange
  • PDLB Nasdaq
  • AQST Nasdaq
  • Market Cap
  • PDLB 285.3M
  • AQST 274.4M
  • IPO Year
  • PDLB 2017
  • AQST 2018
  • Fundamental
  • Price
  • PDLB $12.70
  • AQST $3.27
  • Analyst Decision
  • PDLB
  • AQST Strong Buy
  • Analyst Count
  • PDLB 0
  • AQST 7
  • Target Price
  • PDLB N/A
  • AQST $10.57
  • AVG Volume (30 Days)
  • PDLB 42.2K
  • AQST 1.5M
  • Earning Date
  • PDLB 04-29-2025
  • AQST 03-05-2025
  • Dividend Yield
  • PDLB N/A
  • AQST N/A
  • EPS Growth
  • PDLB 212.14
  • AQST N/A
  • EPS
  • PDLB 0.46
  • AQST N/A
  • Revenue
  • PDLB $82,359,000.00
  • AQST $57,561,000.00
  • Revenue This Year
  • PDLB $10.97
  • AQST N/A
  • Revenue Next Year
  • PDLB $8.59
  • AQST $35.72
  • P/E Ratio
  • PDLB $27.83
  • AQST N/A
  • Revenue Growth
  • PDLB 16.30
  • AQST 13.79
  • 52 Week Low
  • PDLB $7.89
  • AQST $2.24
  • 52 Week High
  • PDLB $13.97
  • AQST $5.80
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 44.70
  • AQST 58.48
  • Support Level
  • PDLB $12.53
  • AQST $2.71
  • Resistance Level
  • PDLB $13.07
  • AQST $3.39
  • Average True Range (ATR)
  • PDLB 0.23
  • AQST 0.21
  • MACD
  • PDLB 0.02
  • AQST 0.08
  • Stochastic Oscillator
  • PDLB 32.91
  • AQST 80.32

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Share on Social Networks: